| Description |
In over twenty presentations from the renowned faculty, pharmaceutical, biotech and academic leaders deliver the newest approaches to cell therapy, regeneration, and the discovery and development of small molecule therapeutics derived from stem cells. The U.S. Food and Drug Administration’s Center for Biologics, the NIH, and government keynotes will address the regulatory environment surrounding stem cells, and answer all of your questions about federal funding submission and policy.
Numerous networking opportunities, panel discussions and workshop sessions are scheduled throughout the meeting to provide you with direct access to the speaking faculty – which over four years has gained recognition as the most distinguished in the field.
|
|
